Data / Form D filings / Liquid Lung DX, Inc.
Liquid Lung DX, Inc.: Form D filing
Liquid Lung DX, Inc., a biotechnology company in Fairfield, CT, filed a Form D with the SEC in 2019. The latest, on March 27, 2019, reports $70,002 sold of a $1 million offering to 2 investors.
Find out what Liquid Lung DX, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 680 STILLSON ROAD, Fairfield, CT, 06824
- Phone
- (203) 414-1723
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1771742
The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 27, 2019 | New notice | $1,000,000 | $70,002 | $929,998 | 2 | Mar 26, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steven Van Fleet | Director | |
| Patrick Lilley | Director | |
| Martin Keiser | Executive Officer, Director | |
| Sean Miot | Director | |
| Martin Keiser, Jr. | Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of Mar 25, 2019 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Liquid Lung DX, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.